Type 2 Diabetes (Metabolic Disorder) - Drugs in Development, 2021
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes - Drugs In Development, 2021, provides an overview of the Type 2 Diabetes (Metabolic Disorders) pipeline landscape.Type 2 diabetes is a chronic condition and is the most common form of diabetes. High levels of glucose are a characteristic feature. The body might become resistant to insulin or may not produce enough amounts. Due to abnormal insulin functioning, glucose is concentrated in the blood leading to elevated levels and hence causing type 2 diabetes. Symptoms include fatigue, weight issues, vision deficits and various other effects. Risk factors include family history, age, obesity, physical inactivity and high blood pressure. This condition is handled by lifestyle alterations and regular medications.
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Type 2 Diabetes - Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Type 2 Diabetes (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Type 2 Diabetes (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Type 2 Diabetes and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 16, 1, 54, 74, 87, 3, 23, 254, 50 and 11 respectively. Similarly, the Universities portfolio in Phase I, IND/CTA Filed, Preclinical and Discovery stages comprises 2, 1, 59 and 16 molecules, respectively.
Type 2 Diabetes (Metabolic Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Type 2 Diabetes (Metabolic Disorders).
- The pipeline guide reviews pipeline therapeutics for Type 2 Diabetes (Metabolic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Type 2 Diabetes (Metabolic Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Type 2 Diabetes (Metabolic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Type 2 Diabetes (Metabolic Disorders)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Type 2 Diabetes (Metabolic Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Type 2 Diabetes (Metabolic Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Type 2 Diabetes (Metabolic Disorder) - Drugs in Development, 2021
Table of Contents
Introduction
Type 2 Diabetes - Overview
Type 2 Diabetes - Therapeutics Development
Type 2 Diabetes - Therapeutics Assessment
Type 2 Diabetes - Companies Involved in Therapeutics Development
Type 2 Diabetes - Drug Profiles
Type 2 Diabetes - Dormant Projects
Type 2 Diabetes - Discontinued Products
Type 2 Diabetes - Product Development Milestones
Appendix
List of Tables
Number of Products under Development for Type 2 Diabetes, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Type 2 Diabetes - Pipeline by 3SBio Inc, 2021
Type 2 Diabetes - Pipeline by Abarceo Pharma AB, 2021
Type 2 Diabetes - Pipeline by Adare Pharma Solutions, 2021
Type 2 Diabetes - Pipeline by Addpharma Inc, 2021
Type 2 Diabetes - Pipeline by ADM Therapeutics, 2021
Type 2 Diabetes - Pipeline by Adocia SAS, 2021
Type 2 Diabetes - Pipeline by Aerami Therapeutics Inc, 2021
Type 2 Diabetes - Pipeline by Afimmune Biopharma Ltd, 2021
Type 2 Diabetes - Pipeline by Agentix Corp, 2021
Type 2 Diabetes - Pipeline by AgeX Therapeutics Inc, 2021
Type 2 Diabetes - Pipeline by Aju Pharm Co Ltd, 2021
Type 2 Diabetes - Pipeline by Akero Therapeutics Inc, 2021
Type 2 Diabetes - Pipeline by Akston Biosciences Corp, 2021
Type 2 Diabetes - Pipeline by Algiax Pharmaceuticals GmbH, 2021
Type 2 Diabetes - Pipeline by Alms Therapeutics, 2021
Type 2 Diabetes - Pipeline by Alnylam Pharmaceuticals Inc, 2021
Type 2 Diabetes - Pipeline by AlphaMab Co Ltd, 2021
Type 2 Diabetes - Pipeline by Altimmune Inc, 2021
Type 2 Diabetes - Pipeline by AltrixBio Inc, 2021
Type 2 Diabetes - Pipeline by Amide Technologies Inc, 2021
Type 2 Diabetes - Pipeline by AmideBio LLC, 2021
Type 2 Diabetes - Pipeline by Anagenesis Biotechnologies SAS, 2021
Type 2 Diabetes - Pipeline by Ananda Scientific Inc, 2021
Type 2 Diabetes - Pipeline by Anji Pharmaceuticals Inc, 2021
Type 2 Diabetes - Pipeline by AnyGen Co Ltd, 2021
Type 2 Diabetes - Pipeline by Apcegen Technologies Pvt Ltd, 2021
Type 2 Diabetes - Pipeline by Aphios Corp, 2021
Type 2 Diabetes - Pipeline by Apoglyx AB, 2021
Type 2 Diabetes - Pipeline by Dong-A ST Co Ltd, 2021
Type 2 Diabetes - Pipeline by EastGate Pharmaceuticals Inc, 2021
Type 2 Diabetes - Pipeline by Eccogene (Shanghai) Co Ltd, 2021
Type 2 Diabetes - Pipeline by Egy-Nano Pharma LP, 2021
Type 2 Diabetes - Pipeline by Elevian Inc, 2021
Type 2 Diabetes - Pipeline by Eli Lilly and Co, 2021
Type 2 Diabetes - Pipeline by Emerald Organic Products Inc, 2021
Type 2 Diabetes - Pipeline by Emmaus Life Sciences Inc, 2021
Type 2 Diabetes - Pipeline by Empros Pharma AB, 2021
Type 2 Diabetes - Pipeline by EncuraGen Inc, 2021
Type 2 Diabetes - Pipeline by Energenesis Biomedical Co Ltd, 2021
Type 2 Diabetes - Pipeline by Enesi Pharma Ltd, 2021
Type 2 Diabetes - Pipeline by Enteris BioPharma Inc, 2021
Type 2 Diabetes - Pipeline by Enzene Biosciences Ltd, 2021
Type 2 Diabetes - Pipeline by Enzo Biochem Inc, 2021
Type 2 Diabetes - Pipeline by Epichem Pty Ltd, 2021
Type 2 Diabetes - Pipeline by Eternygen GmbH, 2021
Type 2 Diabetes - Pipeline by Evotec SE, 2021
Type 2 Diabetes - Pipeline by F. Hoffmann-La Roche Ltd, 2021
Type 2 Diabetes - Pipeline by Fairbanks Pharmaceuticals Inc, 2021
Type 2 Diabetes - Pipeline by Fochon Pharmaceutical Ltd, 2021
Type 2 Diabetes - Pipeline by Forkhead BioTherapeutics Inc, 2021
Type 2 Diabetes - Pipeline by FortuneRock (China) Ltd, 2021
Type 2 Diabetes - Pipeline by Fujian Haixi New Medicine Creation Co Ltd, 2021
Type 2 Diabetes - Pipeline by Gan & Lee Pharmaceuticals Co Ltd, 2021
Type 2 Diabetes - Pipeline by Generex Biotechnology Corp, 2021
Type 2 Diabetes - Pipeline by Genexine Inc, 2021
Type 2 Diabetes - Pipeline by Genovate Biotechnology Co LTD, 2021
Type 2 Diabetes - Pipeline by Genprex Inc, 2021
Type 2 Diabetes - Pipeline by Geropharm, 2021
Type 2 Diabetes - Pipeline by GL Pharm Tech Corp, 2021
Type 2 Diabetes - Pipeline by Glaceum Inc, 2021
Type 2 Diabetes - Pipeline by Glucox Biotech AB, 2021
Type 2 Diabetes - Pipeline by Glyscend Inc, 2021
Type 2 Diabetes - Pipeline by Gmax Biopharm LLC, 2021
Type 2 Diabetes - Pipeline by Guangdong Zhongsheng Pharmaceutical Co Ltd, 2021
Type 2 Diabetes - Pipeline by Guangzhou Magpie Pharmaceutical Co Ltd, 2021
Type 2 Diabetes - Pipeline by Gubra ApS, 2021
Type 2 Diabetes - Pipeline by Gusto Global LLC, 2021
Type 2 Diabetes - Pipeline by Hangzhou East China Pharmaceutical Group Co Ltd, 2021
Type 2 Diabetes - Pipeline by Hangzhou Jiuyuan Gene Engineering Co Ltd, 2021
Type 2 Diabetes - Pipeline by Hanmi Pharmaceuticals Co Ltd, 2021
Type 2 Diabetes - Pipeline by HCW Biologics Inc, 2021
Type 2 Diabetes - Pipeline by HEC Pharma Co Ltd, 2021
Type 2 Diabetes - Pipeline by Hefei Industrial Pharmaceutical Institute Co Ltd, 2021
Type 2 Diabetes - Pipeline by Hengrui Therapeutics Inc, 2021
Type 2 Diabetes - Pipeline by HighTide Therapeutics Inc, 2021
Type 2 Diabetes - Pipeline by HK inno.N Corp, 2021
Type 2 Diabetes - Pipeline by Housey Pharmaceutical Research Laboratories LLC, 2021
Type 2 Diabetes - Pipeline by Hua Medicine Shanghai Ltd, 2021
Type 2 Diabetes - Pipeline by Huadong Medicine Co Ltd, 2021
Type 2 Diabetes - Pipeline by Hualan Biological Engineering Inc, 2021
Type 2 Diabetes - Pipeline by Hyundai Pharma Co Ltd, 2021
Type 2 Diabetes - Pipeline by Ildong Pharmaceutical Co Ltd, 2021
Type 2 Diabetes - Pipeline by Imagine Pharma LLC, 2021
Type 2 Diabetes - Pipeline by Immunwork Inc, 2021
Type 2 Diabetes - Pipeline by Immupharma Plc, 2021
Type 2 Diabetes - Pipeline by Immuron Ltd, 2021
Type 2 Diabetes - Pipeline by Impetis Biosciences Ltd, 2021
Type 2 Diabetes - Pipeline by Inflammasome Therapeutics Inc, 2021
Type 2 Diabetes - Pipeline by Innovimmune Biotherapeutics Inc, 2021
Type 2 Diabetes - Pipeline by Inspyr Therapeutics Inc, 2021
Type 2 Diabetes - Pipeline by Intarcia Therapeutics Inc, 2021
Type 2 Diabetes - Pipeline by Integral Molecular Inc, 2021
Type 2 Diabetes - Pipeline by Ionis Pharmaceuticals Inc, 2021
Type 2 Diabetes - Pipeline by Japan Tobacco Inc, 2021
Type 2 Diabetes - Pipeline by Jeil Pharmaceutical Co Ltd, 2021
Type 2 Diabetes - Pipeline by Jiangsu Chia-tai Tianqing Pharmaceutical Co Ltd, 2021
Type 2 Diabetes - Pipeline by Jiangsu Hansoh Pharmaceutical Group Co Ltd, 2021
Type 2 Diabetes - Pipeline by Jiangsu Hengrui Medicine Co Ltd, 2021
Type 2 Diabetes - Pipeline by Jiangsu Lianhuan Pharmaceutical Co Ltd, 2021
Type 2 Diabetes - Pipeline by Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd, 2021
Type 2 Diabetes - Pipeline by Jiangsu T-mab BioPharma Co Ltd, 2021
Type 2 Diabetes - Pipeline by Johnson & Johnson, 2021
Type 2 Diabetes - Pipeline by Kadimastem Ltd, 2021
Type 2 Diabetes - Pipeline by Kaneq Bioscience Ltd, 2021
Type 2 Diabetes - Pipeline by Karyo Biologics LLC, 2021
Type 2 Diabetes - Pipeline by KB Biomed Inc, 2021
Type 2 Diabetes - Pipeline by Klotho Therapeutics Inc, 2021
Type 2 Diabetes - Pipeline by Kolmar Korea Co Ltd, 2021
Type 2 Diabetes - Pipeline by Kriya Therapeutics Inc, 2021
Type 2 Diabetes - Pipeline by Kyung Dong Co Ltd, 2021
Type 2 Diabetes - Pipeline by Laboratorios Silanes SA de CV, 2021
Type 2 Diabetes - Pipeline by Lannett Co Inc, 2021
Type 2 Diabetes - Pipeline by Lanzhou Institute of Biological Products Co Ltd, 2021
Type 2 Diabetes - Pipeline by Lead Discovery Center GmbH, 2021
Type 2 Diabetes - Pipeline by Lepu Medical Technology (Beijing) Co Ltd, 2021
Type 2 Diabetes - Pipeline by Levim Biotech LLP, 2021
Type 2 Diabetes - Pipeline by Lexicon Pharmaceuticals Inc, 2021
Type 2 Diabetes - Pipeline by LG Chem Ltd, 2021
Type 2 Diabetes - Pipeline by Oncosimis Biotech Pvt Ltd, 2021
Type 2 Diabetes - Pipeline by OPKO Health Inc, 2021
Type 2 Diabetes - Pipeline by OptiKira LLC, 2021
Type 2 Diabetes - Pipeline by Oramed Pharmaceuticals Inc, 2021
Type 2 Diabetes - Pipeline by Orbsen Therapeutics Ltd, 2021
Type 2 Diabetes - Pipeline by Original BioMedicals Co Ltd, 2021
Type 2 Diabetes - Pipeline by Palatin Technologies Inc, 2021
Type 2 Diabetes - Pipeline by Palisade Bio, Inc, 2021
Type 2 Diabetes - Pipeline by Panorama Researchama Research, 2021
Type 2 Diabetes - Pipeline by Paras Biopharmaceuticals Finland Oy, 2021
Type 2 Diabetes - Pipeline by Park Active Molecules, 2021
Type 2 Diabetes - Pipeline by PegBio Co Ltd, 2021
Type 2 Diabetes - Pipeline by Peptron Inc, 2021
Type 2 Diabetes - Pipeline by Pfizer Inc, 2021
Type 2 Diabetes - Pipeline by PharmaCyte Biotech Inc, 2021
Type 2 Diabetes - Pipeline by Pila Pharma AB, 2021
Type 2 Diabetes - Pipeline by Polus Inc, 2021
Type 2 Diabetes - Pipeline by Poxel SA, 2021
Type 2 Diabetes - Pipeline by Preveceutical Medical Inc, 2021
Type 2 Diabetes - Pipeline by ProLynx LLC, 2021
Type 2 Diabetes - Pipeline by Prometheon Pharma LLC, 2021
Type 2 Diabetes - Pipeline by Protheragen Inc, 2021
Type 2 Diabetes - Pipeline by Prous Institute for Biomedical Research SA, 2021
Type 2 Diabetes - Pipeline by Purzer Pharmaceutical Co Ltd, 2021
Type 2 Diabetes - Pipeline by Qoracle Co Ltd, 2021
Type 2 Diabetes - Pipeline by QuiaPEG Pharmaceuticals AB, 2021
Type 2 Diabetes - Pipeline by Rani Therapeutics LLC, 2021
Type 2 Diabetes - Pipeline by Rebio Technologies Ltd, 2021
Type 2 Diabetes - Pipeline by Regenerative Medical Solutions Inc, 2021
Type 2 Diabetes - Pipeline by Remd Biotherapeutics Inc, 2021
Type 2 Diabetes - Pipeline by Remedium Bio Inc, 2021
Type 2 Diabetes - Pipeline by reMYND NV, 2021
Type 2 Diabetes - Pipeline by Renova Therapeutics Inc, 2021
Type 2 Diabetes - Pipeline by Retinset SL, 2021
Type 2 Diabetes - Pipeline by Rezolute Inc, 2021
Type 2 Diabetes - Pipeline by Ridgeline Therapeutics LLC, 2021
Type 2 Diabetes - Pipeline by Rivus Pharmaceuticals Inc, 2021
Type 2 Diabetes - Pipeline by RosVivo Therapeutics Inc, 2021
Type 2 Diabetes - Pipeline by Samik Pharmaceutical Co Ltd, 2021
Type 2 Diabetes - Pipeline by Samjin Pharm Co Ltd, 2021
Type 2 Diabetes - Pipeline by Sanofi, 2021
Type 2 Diabetes - Pipeline by Sanwa Kagaku Kenkyusho Co Ltd, 2021
Type 2 Diabetes - Pipeline by SBI Pharmaceuticals Co Ltd, 2021
Type 2 Diabetes - Pipeline by ScandiCure AB, 2021
Type 2 Diabetes - Pipeline by Sciwind Biosciences Co Ltd, 2021
Type 2 Diabetes - Pipeline by Scohia Pharma Inc, 2021
Type 2 Diabetes - Pipeline by Senseion Inc, 2021
Type 2 Diabetes - Pipeline by Sensulin LLC, 2021
Type 2 Diabetes - Pipeline by Seres Therapeutics Inc, 2021
Type 2 Diabetes - Pipeline by Serodus ASA, 2021
Type 2 Diabetes - Pipeline by Serpin Pharma LLC, 2021
Type 2 Diabetes - Pipeline by Shaanxi Micot Technology Co Ltd, 2021
Type 2 Diabetes - Pipeline by Shandong Baijidichang Pharmaceutical Co Ltd, 2021
Type 2 Diabetes - Pipeline by Shandong Luye Pharmaceutical Co Ltd, 2021
Type 2 Diabetes - Pipeline by Shanghai Fosun Pharmaceutical (Group) Co Ltd, 2021
Type 2 Diabetes - Pipeline by Shanghai HEP Pharmaceutical Co Ltd, 2021
Type 2 Diabetes - Pipeline by Shanghai Innogen Pharmaceutical Technology Co Ltd, 2021
Type 2 Diabetes - Pipeline by Shanghai Yingli Pharmaceutical Co Ltd, 2021
Type 2 Diabetes - Pipeline by Shenzhen Chipscreen Biosciences Co Ltd, 2021
Type 2 Diabetes - Pipeline by Shenzhen Salubris Pharmaceuticals Co Ltd, 2021
Type 2 Diabetes - Pipeline by Shionogi & Co Ltd, 2021
Type 2 Diabetes - Pipeline by Shouyao Holding Co Ltd, 2021
Type 2 Diabetes - Pipeline by Sichuan Haisco Pharmaceutical Co Ltd, 2021
Type 2 Diabetes - Pipeline by Sihuan Pharmaceutical Holdings Group Ltd, 2021
Type 2 Diabetes - Pipeline by Sino Biopharmaceutical Ltd, 2021
Type 2 Diabetes - Pipeline by Sirona Biochem Corp, 2021
Type 2 Diabetes - Pipeline by SJT Molecular Research SL, 2021
Type 2 Diabetes - Pipeline by SK Chemicals Co Ltd, 2021
Type 2 Diabetes - Pipeline by Sosei Group Corp, 2021
Type 2 Diabetes - Pipeline by Stelis Biopharma Pvt Ltd, 2021
Type 2 Diabetes - Pipeline by Sulfateq BV, 2021
Type 2 Diabetes - Pipeline by Sun Pharmaceutical Industries Ltd, 2021
Type 2 Diabetes - Pipeline by Sveikatal Inc, 2021
Type 2 Diabetes - Pipeline by SymbioCellTech LLC, 2021
Type 2 Diabetes - Pipeline by Synokem Pharmaceuticals Ltd, 2021
Type 2 Diabetes - Pipeline by Taisho Pharmaceutical Holdings Co Ltd, 2021
Type 2 Diabetes - Pipeline by Takeda Pharmaceutical Co Ltd, 2021
Type 2 Diabetes - Pipeline by Techfields Pharma Co Ltd, 2021
Type 2 Diabetes - Pipeline by The Healthy Aging Co, 2021
Type 2 Diabetes - Pipeline by The United Laboratories International Holdings Ltd, 2021
Type 2 Diabetes - Pipeline by Theracos Inc, 2021
Type 2 Diabetes - Pipeline by Thermalin Inc, 2021
Type 2 Diabetes - Pipeline by Tonghua Dongbao Pharmaceutical Co Ltd, 2021
Type 2 Diabetes - Pipeline by Torrent Pharmaceuticals Ltd, 2021
Type 2 Diabetes - Dormant Projects, 2021
Type 2 Diabetes - Discontinued Products, 2021
List of Figures
Number of Products under Development for Type 2 Diabetes, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Top 10 Routes of Administration, 2021
Number of Products by Stage and Top 10 Routes of Administration, 2021
Number of Products by Top 10 Molecule Types, 2021
Number of Products by Stage and Top 10 Molecule Types, 2021
Familial Amyloid Neuropathies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published: 28-Dec-2022 Price: US 2000 Onwards Pages: 59
Familial Amyloid Neuropathies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Familial Amyloid Neuropathies - Drugs In Development, 2022, provides an overview of the Familial Amyloid Neuropathies (Metabolic Disorders) pipeline landscape.
Familial amyloid neuropathy is a slowly progressive condition characterized by the bui......
Hyperglycemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published: 28-Dec-2022 Price: US 2000 Onwards Pages: 35
Hyperglycemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperglycemia - Drugs In Development, 2022, provides an overview of the Hyperglycemia (Metabolic Disorders) pipeline landscape.
Hyperglycemia is a condition that occurs when blood glucose levels get too high. Several factors can contribute to hyperglycemia, incl......
Hyperinsulinemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published: 28-Dec-2022 Price: US 2000 Onwards Pages: 54
Hyperinsulinemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperinsulinemia - Drugs In Development, 2022, provides an overview of the Hyperinsulinemia (Metabolic Disorders) pipeline landscape.
Hyperinsulinemia is a condition in which there are excess levels of insulin circulating in the blood relative to the level of......
Pituitary ACTH Hypersecretion (Cushing Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published: 28-Dec-2022 Price: US 2000 Onwards Pages: 37
Pituitary ACTH Hypersecretion (Cushing Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pituitary ACTH Hypersecretion (Cushing Disease) - Drugs In Development, 2022, provides an overview of the Pituitary ACTH Hypersecretion (Cushing Disease) (Metabolic Disorders) pipeline landscape.
Cushing's disease is a condition......
Diabetic Foot Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published: 31-Oct-2022 Price: US 2000 Onwards Pages: 142
Diabetic Foot Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Foot Ulcers - Drugs In Development, 2022, provides an overview of the Diabetic Foot Ulcers (Metabolic Disorders) pipeline landscape.
Diabetic foot ulcers are sores that occur on the feet of people with Type 1 Diabetes and Type 2 Diabetes. Symptom......
Diabetic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published: 31-Oct-2022 Price: US 2000 Onwards Pages: 94
Diabetic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Neuropathy - Drugs In Development, 2022, provides an overview of the Diabetic Neuropathy (Metabolic Disorders) pipeline landscape.
Diabetic neuropathy, a common complication of diabetes, is damage to the nerves that allow feeling things such as pa......
Diabetic Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published: 31-Oct-2022 Price: US 2500 Onwards Pages: 286
Diabetic Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Retinopathy - Drugs In Development, 2022, provides an overview of the Diabetic Retinopathy (Metabolic Disorders) pipeline landscape.
Diabetic retinopathy is a complication of diabetes that affects the eyes. Diabetic retinopathy symptoms may inclu......
Type 1 Diabetes (Juvenile Diabetes) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published: 31-Oct-2022 Price: US 2500 Onwards Pages: 548
Type 1 Diabetes (Juvenile Diabetes) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes (Juvenile Diabetes) - Drugs In Development, 2022, provides an overview of the Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorders) pipeline landscape.
Type 1 diabetes (T1D) is an autoimmune disease in which a pancreas s......
Type 2 Diabetes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published: 31-Oct-2022 Price: US 2500 Onwards Pages: 1127
Type 2 Diabetes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes - Drugs In Development, 2022, provides an overview of the Type 2 Diabetes (Metabolic Disorders) pipeline landscape.
Type 2 diabetes is a chronic condition and is the most common form of diabetes. High levels of glucose are a characteristic feat......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
